# Matinas BioPharma Holdings, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/matinas-biopharma-holdings-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 18 |
| Claims under review | 1 |
| Evidence records | 3 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-15T04:47:21.744472+00:00 |
| Last reviewed | 2026-10-15T04:47:21.744472+00:00 |

## Identity

- Legal name: Matinas BioPharma Holdings, Inc.
- Display name: Matinas BioPharma Holdings, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-16T00:53:02.899319+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.821 |
| Directors | 11 |
| Committees | 1 |
| Governance events | 6 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Eric Ende: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-09-19. claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:7
- Herbert Conrad: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-09-19. claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:9
- James Scibetta: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-09-19. claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:10
- Kathryn Corzo: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-09-19. claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:11
- Matthew Wikler: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-09-19. claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:13
- Natasha Giordano: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:14
- Edward Neugeboren: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:6
- Evelyn D'An: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:8
- Jerome D. Jabbour: Chairman, Chief Executive Officer and President. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and President (chair). claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:5
- Keith Murphy: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:12
- Robin L. Smith: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:15

## Committees

- Chief Executive Officer and President (executive). Chair: Jerome D. Jabbour. Members: Jerome D. Jabbour (chair, unknown). committee_id=alpha:committee:matinas-biopharma-holdings-inc:chief-executive-officer-and-president

## Executive leadership

- Jerome D. Jabbour: Chairman, Chief Executive Officer and President [CEO]. Status: unknown. claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:16
- Keith A. Kucinski: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:17

## Governance events

- DIRECTOR_APPOINTED: Eric Ende seat on Matinas BioPharma Holdings, Inc., effective 2023-09-19. Effective: 2023-09-19. Detected: 2026-10-15T04:47:21.744472+00:00. event_id=alpha:event:transition:da9709144jxtb
- DIRECTOR_APPOINTED: Herbert Conrad seat on Matinas BioPharma Holdings, Inc., effective 2023-09-19. Effective: 2023-09-19. Detected: 2026-10-15T04:47:21.744472+00:00. event_id=alpha:event:transition:2k0egfhx3ivl
- DIRECTOR_APPOINTED: James Scibetta seat on Matinas BioPharma Holdings, Inc., effective 2023-09-19. Effective: 2023-09-19. Detected: 2026-10-15T04:47:21.744472+00:00. event_id=alpha:event:transition:libhvh1tp44xh
- DIRECTOR_APPOINTED: Kathryn Corzo seat on Matinas BioPharma Holdings, Inc., effective 2023-09-19. Effective: 2023-09-19. Detected: 2026-10-15T04:47:21.744472+00:00. event_id=alpha:event:transition:1uy3zeym2zzyw
- DIRECTOR_APPOINTED: Matthew Wikler seat on Matinas BioPharma Holdings, Inc., effective 2023-09-19. Effective: 2023-09-19. Detected: 2026-10-15T04:47:21.744472+00:00. event_id=alpha:event:transition:6nj2a21elkg66
- DIRECTOR_APPOINTED: Natasha Giordano seat on Matinas BioPharma Holdings, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-15T04:47:21.744472+00:00. event_id=alpha:event:transition:10aplpd1wqr0b3

## Scoped resources

- `alpha://company/matinas-biopharma-holdings-inc` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record
- `alpha://company/matinas-biopharma-holdings-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=identity
- `alpha://company/matinas-biopharma-holdings-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=corporate-structure
- `alpha://company/matinas-biopharma-holdings-inc/board` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=board
- `alpha://company/matinas-biopharma-holdings-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=committees
- `alpha://company/matinas-biopharma-holdings-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=leadership
- `alpha://company/matinas-biopharma-holdings-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=ownership
- `alpha://company/matinas-biopharma-holdings-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=financials
- `alpha://company/matinas-biopharma-holdings-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=capital-structure
- `alpha://company/matinas-biopharma-holdings-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=compensation
- `alpha://company/matinas-biopharma-holdings-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=governance
- `alpha://company/matinas-biopharma-holdings-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=shareholder-governance
- `alpha://company/matinas-biopharma-holdings-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=audit
- `alpha://company/matinas-biopharma-holdings-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=legal
- `alpha://company/matinas-biopharma-holdings-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=risk
- `alpha://company/matinas-biopharma-holdings-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=cyber
- `alpha://company/matinas-biopharma-holdings-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=ai-governance
- `alpha://company/matinas-biopharma-holdings-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=agents
- `alpha://company/matinas-biopharma-holdings-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=ecosystem
- `alpha://company/matinas-biopharma-holdings-inc/events` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=events
- `alpha://company/matinas-biopharma-holdings-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=relationships
- `alpha://company/matinas-biopharma-holdings-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=assessments
- `alpha://company/matinas-biopharma-holdings-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Jerome D. Jabbour: Chairman, Chief Executive Officer and President. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1e27d41b60923f6bfa4c8f9ad724d8620e17242a185e0174f8ee15e5c4059553.
- Edward Neugeboren: Director. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1e27d41b60923f6bfa4c8f9ad724d8620e17242a185e0174f8ee15e5c4059553.
- Eric Ende: Director. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:7. Valid from: 2023-09-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b11d9524de9cf7c79982d9162bde059f17af2231730f68dc6ed5c3c2e4952443.
- Evelyn D'An: Director. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1e27d41b60923f6bfa4c8f9ad724d8620e17242a185e0174f8ee15e5c4059553.
- Herbert Conrad: Director. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:9. Valid from: 2023-09-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b11d9524de9cf7c79982d9162bde059f17af2231730f68dc6ed5c3c2e4952443.
- James Scibetta: Director. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:10. Valid from: 2023-09-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b11d9524de9cf7c79982d9162bde059f17af2231730f68dc6ed5c3c2e4952443.
- Kathryn Corzo: Director. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:11. Valid from: 2023-09-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b11d9524de9cf7c79982d9162bde059f17af2231730f68dc6ed5c3c2e4952443.
- Keith Murphy: Director. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1e27d41b60923f6bfa4c8f9ad724d8620e17242a185e0174f8ee15e5c4059553.
- Matthew Wikler: Director. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:13. Valid from: 2023-09-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b11d9524de9cf7c79982d9162bde059f17af2231730f68dc6ed5c3c2e4952443.
- Natasha Giordano: Director. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:14. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b11d9524de9cf7c79982d9162bde059f17af2231730f68dc6ed5c3c2e4952443.
- Robin L. Smith: Director. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1e27d41b60923f6bfa4c8f9ad724d8620e17242a185e0174f8ee15e5c4059553.
- Jerome D. Jabbour: Chairman, Chief Executive Officer and President. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1e27d41b60923f6bfa4c8f9ad724d8620e17242a185e0174f8ee15e5c4059553.
- Keith A. Kucinski: Chief Financial Officer. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1e27d41b60923f6bfa4c8f9ad724d8620e17242a185e0174f8ee15e5c4059553.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Matinas BioPharma Holdings, Inc.. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0189884e02959afb396d66d4e7b35bef134a366e970e30c8c922a17e54922bd8.

## Entity Status

- Public listing published. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0189884e02959afb396d66d4e7b35bef134a366e970e30c8c922a17e54922bd8.

## Published Fact

- US. Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0189884e02959afb396d66d4e7b35bef134a366e970e30c8c922a17e54922bd8.

## Security Listing

- MTNB (NYSE). Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:security_listing:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0189884e02959afb396d66d4e7b35bef134a366e970e30c8c922a17e54922bd8.
- MTNB (NYSE AMERICAN). Claim: alpha:claim:company:9e62f87d-c431-44c7-9fed-bc6dc34eb3a0:security_listing:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0189884e02959afb396d66d4e7b35bef134a366e970e30c8c922a17e54922bd8.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:0189884e02959afb396d66d4e7b35bef134a366e970e30c8c922a17e54922bd8: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc).
- alpha:projection-evidence:document:1e27d41b60923f6bfa4c8f9ad724d8620e17242a185e0174f8ee15e5c4059553: [SEC DEF 14A 0001641172-25-009754](https://www.sec.gov/Archives/edgar/data/1582554/000164117225009754/formdef14-a.htm).
- alpha:projection-evidence:document:b11d9524de9cf7c79982d9162bde059f17af2231730f68dc6ed5c3c2e4952443: [DEF 14A formdef14a.htm](https://www.sec.gov/Archives/edgar/data/1582554/000149315223033102/formdef14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/matinas-biopharma-holdings-inc)
- [Public Markdown](https://registry.alpha.ac/companies/matinas-biopharma-holdings-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/matinas-biopharma-holdings-inc?format=jsonld)
- MCP resource: `alpha://companies/matinas-biopharma-holdings-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-16T00:53:02.637152+00:00; recorded 2026-10-16T00:53:02.637152+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.